FDA Approves Jideytro (Zidesamtinib) for Adults With ROS1-Positive Non-Small Cell Lung Cancer by Madaline Spencer| Published on: Jul 27, 2026

https://checkrare.com/fda-approves-jideytro-zidesamtinib-for-adults-with-ros1-positive-non-small-cell-lung-cancer/ The US Food and Drug Administration (FDA) has approved Jideytro (zidesamtinib) for the treatment of adult patients with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC) who have received a prior ROS1 kinase inhibitor.